Publication reviews long-acting growth hormones for GH deficiency

On September 11, 2026, a new publication titled "Treatment of growth hormone deficiency with long-acting growth hormones in children, adolescents and adults: Clinical evidence and practical considerations" appeared in the journal Annales d'endocrinologie. The publication addresses somatropin recombinant in the context of long-acting growth hormone formulations used for growth hormone deficiency across pediatric, adolescent, and adult populations. It is described as covering clinical evidence and practical considerations related to this treatment approach. No specific findings, outcomes, or data points from the publication were provided beyond its title, journal, and date. Somatropin recombinant currently carries an unapproved research status as noted in this report. Readers interested in the compound can consult the compound overview for additional background and context on somatropin recombinant.